Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2335]

EMCC 2011: Zoledronic acid reduces the recurrence of breast cancer in post-menopausal women

EMCC 2011: Zoledronic acid reduces the recurrence of breast cancer in post-menopausal women

EMCC 2011: Breast cancer tumour make-up changes through the course of disease; regular biopsies needed to ensure correct treatment

EMCC 2011: Breast cancer tumour make-up changes through the course of disease; regular biopsies needed to ensure...

EMCC 2011: Bone-targeting drug delays onset of prostate cancer metastases

EMCC 2011: Bone-targeting drug delays onset of prostate cancer metastases

EMCC 2011: Radiotherapy between or during chemotherapy cycles 'reduces risk of breast cancer recurrence'

EMCC 2011: Radiotherapy between or during chemotherapy cycles 'reduces risk of breast cancer recurrence'

EMCC 2011: Phase II study shows new cancer drug combination significantly delays breast cancer progression

EMCC 2011: Phase II study shows new cancer drug combination significantly delays breast cancer progression

EMCC 2011: Phase III trial shows improved survival in patients with bone metastases and advanced prostate cancer

EMCC 2011: Phase III trial shows improved survival in patients with bone metastases and advanced prostate cancer

EMCC 2011: Two new cost effective ways to predict prostate cancer

EMCC 2011: Two new cost effective ways to predict prostate cancer

EMCC 2011: Infusing chemotherapy directly into the liver delivers extra months of disease-free life for melanoma patients

EMCC 2011: Infusing chemotherapy directly into the liver delivers extra months of disease-free life for melanoma...

Skin cancer expert to lead Manchester's Paterson Institute

Skin cancer expert to lead Manchester's Paterson Institute

Study points to new strategy to overcome cetuximab resistance

Study points to new strategy to overcome cetuximab resistance

More from ecancer